Form 4: Director Vickie Capps Receives Orthofix Stock Award

Orthofix Medical Inc. director Vickie L. Capps was granted 14,965 deferred stock units as part of an equity compensation award.

Summary

• Director Vickie L. Capps acquired 14,965 deferred stock units on June 10, 2026.
• The award represents a contingent right to receive one share of common stock per unit.
• The units vest in full on the first anniversary of the grant date, contingent upon continued service.
• Following this transaction, the reporting person beneficially owns 43,300 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

• The grant aligns the director's interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified; this is a standard equity compensation disclosure.

Risks

• Vesting of the deferred stock units is subject to the reporting person's continued service through the first anniversary of the grant date.

Future Outlook

The deferred stock units will vest on June 10, 2027, and will settle into common stock within 45 days of the director's termination of service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the medical device industry to ensure board alignment with long-term performance.

Comparison to Industry Standards

• The use of deferred stock units for director compensation is consistent with standard practices among mid-cap medical technology companies.
• The vesting schedule of one year is typical for annual director equity retainers.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation award.

Next Steps

• Vesting of the 14,965 deferred stock units on June 10, 2027.

Key Dates

Keywords

Orthofix Medical, OFIX, Form 4, Insider Trading, Equity Compensation, Director Compensation